A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell Tumors

Background/Aim: The occurrence of germ cell tumour (GCT) in the elderly is rare, with scarce data available. The aim of this study was to understand the clinical outcomes of patients with GCT in patients aged > 45 years. Materials and Methods: A retrospective study was conducted in a large tertia...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2022-10, Vol.14 (20), p.4977
Main Authors: Sharma, Anand, Morrison, Laura, Milic, Marina, Ghose, Aruni, Gogbashian, Andrew, Vasdev, Nikhil, Agarwal, Samita, Pullar, Ben, Rustin, Gordon
Format: Article
Language:English
Subjects:
Age
Aged patients
Biomarkers
Cancer
Care and treatment
Chemotherapy
Communication
Complications and side effects
Germ cell tumors
Hematology
Histology
Metastasis
Methods
Patient outcomes
Patients
Seminoma
Testicular cancer
Toxicity
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Aim: The occurrence of germ cell tumour (GCT) in the elderly is rare, with scarce data available. The aim of this study was to understand the clinical outcomes of patients with GCT in patients aged > 45 years. Materials and Methods: A retrospective study was conducted in a large tertiary cancer centre in north-west London. Between 1 January 2003 and 31 March 2022, 108 cases of GCT in men aged > 45 years were identified and treated at the Mount Vernon Cancer Centre. The median age at diagnosis was 54 years (range = 45−70 years). Results: The 5-year survival rate of all patients was 96%, and the toxicity profile was similar to the younger age group. Conclusion: Older patients with GCT are able to tolerate chemotherapy; however, care must be taken to prevent life-threatening complications using appropriate dose modification.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers14204977